Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 16, 2017 10:51 ET | Source: Fedora Pharmaceuticals, Inc.

Fedora Pharmaceuticals Receives Support from the Government of Canada to Battle Antimicrobial Resistance with Novel Pipeline of Antibiotic Candidates

EDMONTON, Alberta , Jan. 16, 2017 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. announced they have received non-refundable financial contribution from the National Research Council of Canada’s...
November 30, 2015 10:00 ET | Source: Fedora Pharmaceuticals, Inc.

Fedora Pharmaceuticals Receives Alberta Life Sciences "Company of the Year" Award

EDMONTON, Alberta, Nov. 30, 2015 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. today announced that it was named "Company of the Year" by BioAlberta during the Association's 16th Annual General...
November 09, 2015 16:43 ET | Source: Fedora Pharmaceuticals, Inc.

Fedora Pharmaceuticals Inc. Receives 2015 ASTech Award for Outstanding Commercial Achievement

EDMONTON, Alberta, Nov. 9, 2015 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals Inc., a biotechnology company headquartered in Edmonton, Alberta, Canada, announced their receipt of the 2015 Outstanding...
September 12, 2013 13:00 ET | Source: Fedora Pharmaceuticals, Inc.

Fedora Pharmaceuticals Demonstrates that FPI-1465 Increases Activity of Certain Antibiotics against Drug-Resistant Bacteria

EDMONTON, Alberta, Sept. 12, 2013 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. and its collaborators presented results of preclinical studies demonstrating that FPI-1465 increases the activity of...
August 27, 2013 08:00 ET | Source: Fedora Pharmaceuticals, Inc.

Fedora Pharmaceuticals Unveils Details of Antibiotic Resistance Program in 10 Posters at 2013 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)

EDMONTON, Alberta, Aug. 27, 2013 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. today announced that the Company and its collaborators will be presenting 10 posters at the upcoming Interscience...
October 31, 2012 08:00 ET | Source: Fedora Pharmaceuticals, Inc.

Fedora Pharmaceuticals Appoints Ronald Odynski and Dr. Leonard Post to Newly Created Board of Directors

EDMONTON, Alberta, Oct. 31, 2012 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. today announced the creation of a Board of Directors and appointment of Leonard E. Post, Ph.D. and Ronald W. Odynski,...
September 05, 2012 10:00 ET | Source: Fedora Pharmaceuticals, Inc.

Fedora Pharmaceuticals Appoints Thomas R. Parr, Ph.D., Chief Scientific Officer

EDMONTON, Alberta, Sept. 5, 2012 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. today announced the appointment of Thomas Parr, Ph.D. to the newly created role of chief scientific officer. Dr. Parr...